P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY

• Won-Seog Kim,
• Jake Shortt,
• Pier Luigi Zinzani,
• Natalya Mikhaylova,
• Ana Marin-Niebla,
• Dejan Radeski,
• Vincent Ribrag,
• Eva Domingo Domènech,
• Ahmed Sawas,
• Karenza Alexis,
• Michael Emig,
• Linta Garcia,
• Andre Overesch,
• Kerstin Pietzko,
• Steven Horwitz

Affiliations

Won-Seog Kim

1 Sungkyunkwan University School of Medicine, Seoul, Korea, Rep. of South

Jake Shortt

2 Monash University Department of Medicine and Monash Health, Melbourne, Australia

Pier Luigi Zinzani

3 Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy

Natalya Mikhaylova

4 Raisa Gorbacheva Memorial Institute of Children Oncology Hematology and Transplantation, First Saint Petersburg State Pavlov Medical University, Saint Petersburg, Russia

Ana Marin-Niebla

5 Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain

Dejan Radeski

6 Linear Clinical Research & Sir Charles Gairdner Hospital, Perth, Australia

Vincent Ribrag

7 Institut Gustave Roussy, Villejuif, France

Eva Domingo Domènech

8 Institut Catala d’Oncologia. Hospital Duran i Reynals. IDIBELL, Barcelona, Spain

Ahmed Sawas

9 Columbia University Medical Center, New York, United States

Karenza Alexis

10 Affimed Inc., New York, United States

Michael Emig

11 Affimed GmbH, Heidelberg, Germany

Linta Garcia

10 Affimed Inc., New York, United States

Andre Overesch

11 Affimed GmbH, Heidelberg, Germany

Kerstin Pietzko

11 Affimed GmbH, Heidelberg, Germany

Steven Horwitz

12 Memorial Sloan Kettering Cancer Center, New York, United States